Aggressive patenting costs lives, says Oxfam. Legal maneuvering by multinational companies restricting access to essential medicines contradicts their encouraging words at the International AIDS Conference.
Inadequate donor financing and aggressive tactics by multinational pharmaceutical companies threaten to derail efforts to achieve universal access to HIV/AIDS prevention, care, treatment and support by 2010.
In South Africa, the government offers a disability grant which HIV-positive patients can apply for. However, reliance on the grants means recipients have sometimes been willing to take risks with their health to ensure continued eligibility.
Intricate hand-embroidered textiles are brightening the lives of hundreds of South African women affected by HIV. Working together on the quilt helps the women develop bonds and forms part of their emotional support.